Cancer
Mark of Malignancy Identified in Prostate Cancer
Researchers at UConn Health have identified a protein that appears to indicate how aggressive a prostate cancer will be, potentially leading the way to new treatments.
Scientists Pave Path for Tackling Rare Cancers Without Effective Treatments
Genomic analysis is opening the doors to diseases that could never have been understood through traditional biomedical research because there simply aren’t enough patients to observe.
Colonoscopy Just the Start in Preventing Colorectal Cancer
Research at UConn Health has uncovered predictors of the development of polyps that can lead to colorectal cancer.
UConn Health Physician is US Lead on ‘Smash Childhood Cancer’
Pediatric cancer researcher Dr. Ching Lau is spearheading IBM's global crowdsourcing research effort to find new treatments for childhood cancer in the U.S.
UConn Health Researchers Work with Startup on Colon Cancer Vaccine
CaroGen’s proprietary technology platform will be applied to a specific target studied by two immunologists at UConn Health.
Divining Tumor Markers from DNA
UConn Health researchers are part of a cutting-edge initiative to discover cancer markers known as neoantigens, that will further the search for cancer immunotherapies.
Early Detection of Lung Cancer Saves Lives
'Early detection is a patient’s best chance for a lung cancer cure,' says UConn Health's Dr. Omar Ibrahim.
Survivor Seeks to Raise Awareness about Male Breast Cancer
After successful treatment at UConn Health, Norman Smith is now passionate about raising awareness about male breast cancer.
Eliminating the Wait and Worry of Breast Cancer Screenings
'Our goal is to get each woman their screening results in 15 minutes,' says the head of women's imaging at UConn Health.
Major Prostate Cancer Study Supports Watchful Waiting
A study in the New England Journal of Medicine, on which UConn's Dr. Peter Albertsen served as a consultant, supports active surveillance for men with low-grade prostate cancer.